Pharmacotherapy of PTSD in the U.S. Department of Veterans Affairs: diagnostic- and symptom-guided drug selection.
Mohamed S, Rosenheck RA. Pharmacotherapy of PTSD in the U.S. Department of Veterans Affairs: diagnostic- and symptom-guided drug selection. The Journal Of Clinical Psychiatry 2008, 69: 959-65. PMID: 18588361, DOI: 10.4088/jcp.v69n0611.Peer-Reviewed Original ResearchMeSH KeywordsAnti-Anxiety AgentsAntipsychotic AgentsAnxietyComorbidityDrug TherapyFemaleHumansHypnotics and SedativesInternational Classification of DiseasesMaleMiddle AgedPsychotropic DrugsSleep Initiation and Maintenance DisordersStress Disorders, Post-TraumaticUnited StatesUnited States Department of Veterans AffairsConceptsPosttraumatic stress disorderAnxiolytic/Psychotropic medicationsVeterans AffairsMedication classesService usePharmacotherapy of PTSDMental health service useTreatment of PTSDGreater mental health service usePsychotropic medication classesSedative-hypnotic useHealth service useMultivariable logistic regressionAntidepressant useMedication usePsychotropic prescriptionsAntipsychotic useSuch medicationsVA patientsPsychotropic pharmacotherapySymptom responseDepressive disorderVeteran characteristicsSpecific symptoms